OMNILife Sciences

Taunton, United States Founded: 1999 • Age: 27 yrs Acquired By Corin
Hip and knee orthopedic implants are engineered, manufactured, and distributed.
Request Access

About OMNILife Sciences

OMNILife Sciences is a company based in Taunton (United States) founded in 1999 was acquired by Corin in March 2019.. OMNILife Sciences has raised $33.37 million across 7 funding rounds from investors including JPMorgan Chase, Corin Group and Deerfield. OMNILife Sciences offers products and services including ApolloKnee™, Apollo™ Robot, and BalanceBot™. OMNILife Sciences operates in a competitive market with competitors including Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others.

  • Headquarter Taunton, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $33.37 M (USD)

    in 7 rounds

  • Latest Funding Round
    $5 M (USD), Series B

    May 29, 2018

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Corin

    (Mar 08, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of OMNILife Sciences

OMNILife Sciences offers a comprehensive portfolio of products and services, including ApolloKnee™, Apollo™ Robot, and BalanceBot™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables personalized knee replacement planning and execution for better outcomes.

Facilitates precise bone resection in orthopaedic procedures.

Assesses knee balance pre-surgery for optimized surgical plans.

Funding Insights of OMNILife Sciences

OMNILife Sciences has successfully raised a total of $33.37M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series B — $5.0M
  • First Round

    (23 Jan 2009)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Debt – Conventional - OMNILife Sciences Valuation

investors

May, 2018 Amount Series B - OMNILife Sciences Valuation

investors

Jul, 2015 Amount Series B - OMNILife Sciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in OMNILife Sciences

OMNILife Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include JPMorgan Chase, Corin Group and Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare ecosystem is supported through investment and innovation by Deerfield.
Founded Year Domain Location
-
Founded Year Domain Location
Financial services are provided to consumers and corporations worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by OMNILife Sciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - OMNILife Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Omnilife Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of OMNILife Sciences

OMNILife Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of minimally invasive products for musculoskeletal procedures
domain founded_year HQ Location
Develops innovative technologies for spinal and orthopedic implants and instruments.
domain founded_year HQ Location
Orthopedic implants are developed for spine, knee, and arthroscopy procedures.
domain founded_year HQ Location
Large joint primary and revision 3D printed implants for hip and knee, and fixation devices
domain founded_year HQ Location
Implants, instruments, and technologies for joint replacement are developed.
domain founded_year HQ Location
Orthopedic devices and pain management products are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Omnilife Sciences

Frequently Asked Questions about OMNILife Sciences

When was OMNILife Sciences founded?

OMNILife Sciences was founded in 1999 and raised its 1st funding round 10 years after it was founded.

Where is OMNILife Sciences located?

OMNILife Sciences is headquartered in Taunton, United States. It is registered at Taunton, Massachusetts, United States.

Is OMNILife Sciences a funded company?

OMNILife Sciences is a funded company, having raised a total of $33.37M across 7 funding rounds to date. The company's 1st funding round was a Series B of $4M, raised on Jan 23, 2009.

What does OMNILife Sciences do?

OMNILife Sciences was founded in 1999 in Taunton, United States, within the orthopedic devices sector. Hip and knee implants are designed, produced, and distributed, incorporating features developed with surgeon input. A proprietary robotics and navigation platform, OMNInav, is utilized, including computer-assisted cutting guide technology called OMNIplasty. Robotic-assisted solutions like OMNIBotics enable patient-specific total knee replacements.

Who are the top competitors of OMNILife Sciences?

OMNILife Sciences's top competitors include Globus Medical, ExacTech and Implanet.

What products or services does OMNILife Sciences offer?

OMNILife Sciences offers ApolloKnee™, Apollo™ Robot, and BalanceBot™.

Who are OMNILife Sciences's investors?

OMNILife Sciences has 4 investors. Key investors include JPMorgan Chase, Corin Group, Deerfield, and Pioneer Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available